Literature DB >> 7107648

Isolation and characterization of proteoglycans synthesized by human colon and colon carcinoma.

R V Iozzo, T N Wight.   

Abstract

The biosynthesis of proteoglycans in short term organ culture of human colon and colon carcinoma was studied. Proteoglycans, labeled with [35S]sulfate and [3H]serine, were extracted with either 4 M or 0.5 M guanidine HCl in the presence of protease inhibitors and sequentially purified by associative and dissociative CsCl density gradient ultracentrifugation. Normal colon synthesized two polydisperse classes of proteoglycans: a large heparan sulfate-containing monomer, with a Kav of 0.48 on Sepharose CL-2B and a small dermatan sulfate-containing monomer with a Kav of 0.65. A portion (25%) of the proteoglycans was found as aggregate when chromatographed under associative conditions, and the larger monomers interacted with hyaluronic acid to an extent greater than the smaller proteoglycans. Following papain or alkali treatment, the free glycosaminoglycan side chains of both monomers eluted as a single broad peak (Kav = 0.5) from Sepharose CL-6B, with an estimated Mr of 20 X 10(3). In contrast, colon carcinoma synthesized only one proteoglycan monomer, which aggregated to a limited extent (12%). This proteoglycan population, with a Kav of 0.7 on CL-2B, contained chondroitin sulfate as the major glycosaminoglycan (greater than 81%), with small amounts of dermatan sulfate. The glycosaminoglycans had an estimated Mr of 9 X 10(3), and the disaccharides released by chondroitinase ABC consisted of 32% 4-sulfate and 68% 6-sulfate. Electron microscopy of mixed proteoglycancytochrome c monolayers from the associative fractions of normal and neoplastic colon revealed aggregated complexes which were similar in over structure, although smaller than the proteoglycan aggregates from cartilage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7107648

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Structure and function of heparan sulphate proteoglycans.

Authors:  J T Gallagher; M Lyon; W P Steward
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

2.  Comparison of small proteoglycans from skin fibroblasts and vascular smooth-muscle cells.

Authors:  U Rauch; J Glössl; H Kresse
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

3.  Perlecan: the multidomain heparan sulphate proteoglycan of basement membrane and extracellular matrix.

Authors:  A D Murdoch; R V Iozzo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

4.  Biochemical and immunohistochemical analysis of glycosaminoglycans in inflamed and non-inflamed intestinal mucosa of patients with Crohn's disease.

Authors:  Celso L R Belmiro; Heitor S P Souza; Celeste C S Elia; Morgana T L Castelo-Branco; Flavia R Silva; Rosane L Machado; Mauro S G Pavão
Journal:  Int J Colorectal Dis       Date:  2005-01-20       Impact factor: 2.571

5.  Hypomethylation of the decorin proteoglycan gene in human colon cancer.

Authors:  R Adany; R V Iozzo
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

Review 6.  Fibronectin in cell adhesion and invasion.

Authors:  E Ruoslahti
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  Sulphated glycosaminoglycans expression in the basement membranes of colorectal adenocarcinomas. Preliminary study: correlation with histological grading.

Authors:  F Malchiodi-Albedi; F Ciaralli; A Giuliani
Journal:  Histochem J       Date:  1991-05

8.  Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability.

Authors:  M Moczar; F Caux; M Bailly; O Berthier; J F Doré
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

Review 9.  Mechanisms of tumor invasion: evidence from in vivo observations.

Authors:  H Gabbert
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 10.  Proteoglycans and neoplasia.

Authors:  R V Iozzo
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.